Sofia, Bulgaria, June 5, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 4, 2025 the Company sold 42 210 (forty-two thousand two hundred and ten) repurchased own shares representing 0.02% of the share capital of the Company, at a total value of BGN 278 870,64 on the Bulgarian Stock Exchange, the average price per share was BGN 6,61.

Sofia, Bulgaria, June 4, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 3, 2025 the Company sold 12 000 (twelve thousand) repurchased own shares representing 0.007% of the share capital of the Company, at a total value of BGN 80 440 on the Bulgarian Stock Exchange, the average price per share was BGN 6,70.

Sofia, Bulgaria, June 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 2, 2025 the Company sold 5 000 (five thousand) repurchased own shares representing 0.003% of the share capital of the Company, at a total value of BGN 33 560 on the Bulgarian Stock Exchange, the average price per share was BGN 6,71.